Cite

HARVARD Citation

    Jeong, R. et al. (2020). Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin. Canadian journal of kidney health and disease =. p. . [Online]. 
  
Back to record